In-vitro evaluation of the immunomodulatory effects of baricitinib: implication for COVID-19 therapy
COronaVIrus Disease 2019 (COVID-19) is an emerging respiratory infection caused by SARS-CoV-2, reported for the first time in Wuhan (China) and now spread to almost all countries in the world.1
Source: Journal of Infection - Category: Infectious Diseases Authors: Linda Petrone, Elisa Petruccioli, Tonino Alonzi, Valentina Vanini, Gilda Cuzzi, Saeid Najafi Fard, Concetta Castilletti, Fabrizio Palmieri, Gina Gualano, Pietro Vittozzi, Emanuele Nicastri, Luciana Lepore, Alba Grifoni, Andrea Antinori, Alessandra Vergori Source Type: research
More News: China Health | Coronavirus | COVID-19 | Infectious Diseases | Respiratory Medicine | SARS